# Contact PT-141: Reach the Editorial Desk

> Contact the editors of Medicine PT-141, an independent editorial digest of the PT-141 (bremelanotide) research literature. Editorial correspondence only; no medical advice or product sales.

For corrections, sourcing questions, and editorial correspondence about the bremelanotide literature.

## Editorial Correspondence

Use the form below to reach the editors of Medicine PT-141 about the published record on PT-141 (bremelanotide). We welcome corrections, citation queries, and notes on studies we should add — particularly anything that sharpens the accuracy of a measured value or its source.

What this desk does not do: it does not provide medical advice, it does not recommend or supply any compound, and it does not answer requests to purchase, source, or price anything. Bremelanotide is a prescription drug for one approved indication; questions about whether it is appropriate for an individual belong with a licensed prescriber, not with an editorial publisher.

## What to Expect

This is an editorial inbox, not a clinical or commercial one. If you write about a specific number on the site, point us to the page and the figure and we will check it against the cited source. If a citation has been updated, retracted, or annotated since publication, tell us — we treat the citation register as a living document and would rather correct the record than defend it.

We read everything and reply selectively. There is no account, no order, and no consultation attached to this form — only the editorial conversation about what the PT-141 literature actually shows.

---

A precision-metrology readout of the bremelanotide record — each measured value logged to its study and tagged in-spec or disputed, the effect-size debate kept beside the number it qualifies and the field reports fenced off the calibrated panel; no clinic behind the instrument and nothing here dosed, dispensed, or sold.